Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma-Reference-Cited by-同舟云学术

Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma

Published:2024-01-11 Issue:2 Volume:31 Page:86-94
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Schreiner Sarah¹,Berghaus Natalie¹,Poos Alexandra M.²,Raab Marc S.³,Besemer Britta⁴,Fenk Roland⁵,Goldschmidt Hartmut³,Mai Elias K.³,Müller-Tidow Carsten⁶,Weinhold Niels²,Hegenbart Ute¹,Huhn Stefanie²,Schönland Stefan O.¹

Affiliation:

1. Medical Department V, Amyloidosis Center, Heidelberg University Hospital, Heidelberg, Germany

2. Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, Germany

3. Medical Department V, Heidelberg Myeloma Center, Heidelberg University Hospital, National Centre for Tumor Diseases (NCT), Heidelberg, Germany

4. Department of Internal Medicine II, Tübingen University Hospital, Tübingen, Germany

5. Department of Hematology, Oncology, and Clinical Immunology, Düsseldorf University Hospital, Düsseldorf, Germany

6. Medical Department V, Heidelberg University Hospital, Heidelberg, Germany

Funder

deutsche Forschungsgemeinschaft

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13506129.2023.2295221

Reference34 articles.

1. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

2. AL amyloidosis: from molecular mechanisms to targeted therapies

3. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis

4. Structure and function of immunoglobulins

5. The Diversity and Molecular Evolution of B-Cell Receptors during Infection